At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...

Objectives Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) are associated with improved ...

Add-on tafasitamab and lenalidomide did not negatively impact chemotherapy backbone ...

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...

Higher rates of adverse events offset the positive survival results in an area of great unmet need. For decades, the standard ...

The addition of two agents to standard first-line treatment significantly improved PFS among patients with aggressive B-cell lymphomas, according to results of the randomized phase 3 frontMIND ...

frontMIND randomized 899 adults (IPI 3–5; ECOG 0–2) to six 21-day cycles of tafasitamab/lenalidomide/R-CHOP vs placebo/R-CHOP, with investigator-assessed PFS as ...

I’m 70 years old, and my whole family is prone to edema, varicose veins and deep vein thrombosis due to venous insufficiency.

Cymbalta (duloxetine) is a prescription drug that’s used to treat certain kinds of pain, depression, and other conditions. The drug comes as a delayed-release oral capsule. It’s usually taken once or ...

Discover what types of exercises may work best when you have AAV, as well as how to start them and how to avoid taking them ...

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi /Minjuvi) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously ...